4/A
Changes in Ownership
Dianthus Therapeutics, Inc. /DE/ Filed Acc 0000899243-21-019632
Options or other derivatives
- Chief Technical Officer acquired 175,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Nichols David Wayne Chief Technical Officer | 2021-04-19 | Grant or award · Stock Option (Right to Buy) | +175,000 | 175,000 | D | ||
Loading xslF345X03/doc4a.xml…